Blog Posts
The Fundamentals of Extracting Data from the Cold Chain
Innovation comes in many forms and when it comes to extracting data from the cold chain for customers. Tom Weir,...
The True Cost of a Cell & Gene Payload
As the cell and gene industry continues to grow manufacturers must determine where it is – and is not –...
Artificial Intelligence Finally Goes Cold
Tom Weir, Chief Operating Officer for CSafe Global discusses why it has taken so long for AI to come to...
Safeguarding the Cell & Gene Supply Chain – Building Flexibility
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to build flexibility into the cell and gene therapy...
CSafe Global: Built to Excel in Crisis Situations
CSafe Global has a history and mission that has positioned us to perform over and above industry standards no matter...
Safeguarding the Cell & Gene Supply Chain – Part 2
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to mitigate risk in the cell and gene therapy...
Safeguarding the Cell & Gene Supply Chain – Part 1
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to manage compliance in the cell and gene therapy...
Sustainability is in the Box
Larry Fink, BlackRock CEO, published a letter to CEOs regarding sustainability on January 14, 2020. In this blog post our...